| Original language | English |
|---|---|
| Pages (from-to) | 479 - 488 |
| Number of pages | 10 |
| Journal | Journal of Rheumatology |
| Volume | 42 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2015 |
Cite this
}
Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis. / Kavanaugh, Arthur F; Mease, Philip J; Gomez-Reino, Juan Jesus; Adebajo, Adewale O; Wollenhaupt, Jurgen; Gladman, Dafna D; Hochfeld, Marla; Teng, Lichen L; Schett, Georg; Lespessailles, Eric; Hall, Stephen.
In: Journal of Rheumatology, Vol. 42, No. 3, 2015, p. 479 - 488.Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - Longterm (52-week) results of a phase III randomized, controlled trial of apremilast in patients with psoriatic arthritis
AU - Kavanaugh, Arthur F
AU - Mease, Philip J
AU - Gomez-Reino, Juan Jesus
AU - Adebajo, Adewale O
AU - Wollenhaupt, Jurgen
AU - Gladman, Dafna D
AU - Hochfeld, Marla
AU - Teng, Lichen L
AU - Schett, Georg
AU - Lespessailles, Eric
AU - Hall, Stephen
PY - 2015
Y1 - 2015
UR - http://www.jrheum.org/content/42/3/479.full.pdf+html
U2 - 10.3899/jrheum.140647
DO - 10.3899/jrheum.140647
M3 - Article
VL - 42
SP - 479
EP - 488
JO - Journal of Rheumatology
JF - Journal of Rheumatology
SN - 0315-162X
IS - 3
ER -